You Position: Home > Paper

Expressions of EGFR, PCNA and BCL-2 and their prognosis value in human gastric carcinoma

( views:262, downloads:4 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
Issue:
5
DOI:
10.3760/cma.j.issn.1008-6706.2005.05.002
Key Word:
胃肿瘤;基因,bcl-2;基因,erb B-1;增殖细胞核抗原

Abstract: 目的为了寻找胃癌临床病理特征和预后的可靠分子指标,建立一种能被临床普遍应用的简易方法.方法应用SP免疫组化方法,观察具有完整随访资料55例胃癌中EGFR、PCNA及BCL-2的表达情况.结果 (1)EGFR、PCNA及BCL-2的表达与胃癌分期、浸润深度、生存时间呈显著相关性.病变为进展期、深浸润、低生存率者,其表达高(P<0.01).(2)胃癌低分化、有淋巴结转移者的EGFR和PCNA表达率高于高分化和无淋巴结转移者(P<0.05).BCL-2则高分化表达率高,与淋巴结有无转移关系不大(P>0.05).结论测定EGFR、PCNA及BCL-2基因的表达对临床判断预后有较大的帮助.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn